Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

T-cell redirecting bispecific and trispecific antibodies in multiple myeloma beyond BCMA
Niels W.C.J. van de Donk, Chloe O’Neill, Maaike E. M. de Ruijter, et al.
Current Opinion in Oncology (2023) Vol. 35, Iss. 6, pp. 601-611
Open Access | Times Cited: 19

Showing 19 citing articles:

Bispecific and multispecific antibodies in oncology: opportunities and challenges
Maria-Elisabeth Goebeler, Gernot Stuhler, Ralf C. Bargou
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 7, pp. 539-560
Closed Access | Times Cited: 35
Stepping forward: T-cell redirecting bispecific antibodies in cancer therapy
Xiaojing Qin, Wenjing Ning, Han Liu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2361-2377
Open Access | Times Cited: 7
ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cells
Laura Carretero-Iglesia, O. Hall, Jérémy Berret, et al.
Nature Cancer (2024)
Open Access | Times Cited: 6
Pathogenesis, Diagnosis, and Management of Cytokine Release Syndrome in Patients with Cancer: Focus on Infectious Disease Considerations
Panos Arvanitis, Andreas Tziotis, Spyridon Papadimatos, et al.
Current Oncology (2025) Vol. 32, Iss. 4, pp. 198-198
Open Access
Pityriasis lichenoides et varioliformis acuta in a patient treated with cevostamab
Jeremy Orloff, Dev D. Patel, Camille M. Powers, et al.
JAAD Case Reports (2024) Vol. 47, pp. 23-25
Open Access | Times Cited: 3
Enhancing Fc‐mediated effector functions of monoclonal antibodies: The example of HexaBodies
Hilma J. van der Horst, Tuna Mutis
Immunological Reviews (2024)
Open Access | Times Cited: 3
Beyond BCMA: the next wave of CAR T cell therapy in multiple myeloma
Kevin C. Miller, Hamza Hashmi, Sridevi Rajeeve
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Updates on Therapeutic Strategies in the Treatment of Relapsed/Refractory Multiple Myeloma
Deevyashali Parekh, Yun Kyoung Tiger, Kevin Tony Jamouss, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 2931-2931
Open Access | Times Cited: 2
Talquetamab in Multiple Myeloma: Efficacy, Safety, and Future Directions
Caterina Labanca, Enrica Antonia Martino, Ernesto Vigna, et al.
European Journal Of Haematology (2024)
Closed Access | Times Cited: 2
IL-15/IL-15Rα-Fc-Fusion Protein XmAb24306 Potentiates Activity of CD3 Bispecific Antibodies through Enhancing T-Cell Expansion
Ji Li, Robyn Clark, Dionysos Slaga, et al.
Molecular Cancer Therapeutics (2024) Vol. 23, Iss. 9, pp. 1305-1316
Closed Access | Times Cited: 1
Fast and furious: Changing gears on the road to cure with chimeric antigen receptor T cells in multiple myeloma
Nico Gagelmann, Maximilian Merz
Seminars in Hematology (2024) Vol. 61, Iss. 5, pp. 306-313
Open Access | Times Cited: 1
T-cell redirecting bispecific antibody treatment in multiple myeloma: current knowledge and future strategies for sustained T-cell engagement
Marise R. Heerma van Voss, Remco J. Molenaar, Charlotte L.B.M. Korst, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 9, pp. 889-901
Open Access | Times Cited: 1
Talquetamab: A promising immunotherapy for multiple myeloma
Amna Tariq, Abdul Wahid, Fatima Asif, et al.
Rare Tumors (2023) Vol. 15
Open Access | Times Cited: 3
Editorial: Multiple Myeloma: Molecular Mechanism and Targeted Therapy
Despina Bazou, Paul Dowling
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3799-3799
Open Access
In vivo expression of an mRNA encoded multi-mechanistic mAb combination against Staphylococcus aureus and protection in disease model
Christine Tkaczyk, Michael Newton, Mun Mun Patnaik, et al.
Molecular Therapy (2024) Vol. 32, Iss. 8, pp. 2505-2518
Open Access
Are we there yet? CAR‐T therapy in multiple myeloma
Eitan Mirvis, Reuben Benjamin
British Journal of Haematology (2024)
Open Access
Expert opinion on multiple myeloma treatment in Brazil in the bispecific antibody era
Vânia Hungria, Jorge Vaz Pinto Neto, Pedro Manoel Marques Garibaldi, et al.
Clinical Lymphoma Myeloma & Leukemia (2024)
Closed Access
Antibody-Based Immunotherapies for the Treatment of Hematologic Malignancies
Justyna Jureczek, Krzysztof Kałwak, Piotr Dzięgiel
Cancers (2024) Vol. 16, Iss. 24, pp. 4181-4181
Open Access
Myélome multiple : stratégies et objectifs de traitement
Arthur Bobin, Xavier Leleu, Aurore Perrot
Encyclopédie médico-chirurgicale. Hématologie (2024) Vol. 35, Iss. 3, pp. 1-9
Closed Access
Page 1

Scroll to top